Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033200 · ClinicalTrials.gov registry record · Phase 4
Safety Study Looking at the Effects of Stendra on Vision
A Phase 4 study, sponsored by VIVUS.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT02033200 is a Phase 4 study that has completed, run by VIVUS. The registered enrollment target is 80 participants.
The verdict
NCT02033200, a Phase 4 study, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.
Interventions
- DRUG Placebo
- DRUG Stendra 200 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02033200
The ClinicalTrials.gov registry entry for NCT02033200 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02033200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02033200 about?
NCT02033200 is a clinical study titled "Safety Study Looking at the Effects of Stendra on Vision". The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.
What is the current status of trial NCT02033200?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2014-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02033200?
The interventions under investigation include: Placebo (DRUG), Stendra 200 mg (DRUG).
Who is sponsoring clinical trial NCT02033200?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.